Literature DB >> 32552002

An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.

Anna K Lugnér1, Paul F M Krabbe2.   

Abstract

INTRODUCTION: Preference-based instruments measuring health status express the value of specific health states in a single number. One method used is time trade-off (TTO). Health-status values are key elements in calculating quality-adjusted life years (QALYs) and are pertinent for resource allocation. Since they are used in economic evaluations of healthcare, searching for a theoretical foundation of TTO in economics is justified. AREA COVERED: This paper provides an overview of TTO, including its relation to economic theory, and discusses biases and distortions, compiled from recent and older research. Inconsistencies between TTO and random utility theory were detected; The TTO is confounded by time preferences and by respondents' life expectancies. TTO is cognitively challenging, therefore guidance during the interviews is needed, producing interview effects. TTO does not measure one thing at a time, nor are the values independent of other states that are being valued in the same task. That is, TTO does not exhibit theoretical measurement properties such as unidimensionality and the invariance principle. EXPERT OPINION: We conclude that the TTO may be a pragmatic method of eliciting health state values, but the limitations in regard to measurement theory and practical elicitation problems makes it prone to inconsistencies and arbitrariness.

Entities:  

Keywords:  Economic evaluation; QALY; health related quality of life; health state valuation; pharmacoeconomics; utilities

Mesh:

Year:  2020        PMID: 32552002     DOI: 10.1080/14737167.2020.1779062

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  10 in total

1.  Willingness to Pay and Time Trade-off in Thai Patients with Port-Wine Stains.

Authors:  Tatre Jantarakolica; Rungsima Wanitphakdeedecha; Chadakan Yan; Yuri Yogya; Surachet Sirisuthivoranunt; Supisara Wongdama; Phumithep Phumariyapong; Tatchalerm Sudhipongpracha
Journal:  Clinicoecon Outcomes Res       Date:  2022-09-22

2.  Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic Review.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2021-06-10

3.  To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value Claims.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-12-10

4.  The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER).

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-07-31

5.  Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain.

Authors:  Anabel Estévez-Carrillo; Sarah Dewilde; Mark Oppe; Juan M Ramos-Goñi
Journal:  Patient       Date:  2022-02-16       Impact factor: 3.481

6.  Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.

Authors:  Daniel O Claassen; Rajeev Ayyagari; Debbie Goldschmidt; Mo Zhou; Sam Leo; Rinat Ribalov
Journal:  Adv Ther       Date:  2022-02-23       Impact factor: 3.845

7.  Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  Eur J Health Econ       Date:  2022-09-02

8.  Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study.

Authors:  Sahar Al Shabasy; Fatima Al Sayah; Maggie Abbassi; Samar Farid
Journal:  Patient       Date:  2022-02-14       Impact factor: 3.481

9.  Peter Rabbit is a Badger in Disguise: Deconstructing the Belief System of the Institute for Clinical and Economic Review in Health Technology Assessment.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2021-05-25

10.  EQ-5D-5L Health-State Values for the Mexican Population.

Authors:  Cristina Gutierrez-Delgado; Rosa-María Galindo-Suárez; Cesar Cruz-Santiago; Koonal Shah; Manny Papadimitropoulos; Yan Feng; Bernarda Zamora; Nancy Devlin
Journal:  Appl Health Econ Health Policy       Date:  2021-06-26       Impact factor: 2.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.